Chronic refractory breathlessness is a distinct clinical syndrome

Current Opinion in Supportive and Palliative Care

Volumn 9, Issue 3, 2015, Pages 203-205

  Johnson, Miriam J ^a   Currow, David C ^b,c,d  

^a UNIVERSITY OF HULL   (United Kingdom)

^b FLINDERS UNIVERSITY   (Australia)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; CLASSIFICATION; DYSPNEA; HUMAN; PALLIATIVE THERAPY; PSYCHOLOGY; SYNDROME;

CHRONIC DISEASE; DYSPNEA; HUMANS; PALLIATIVE CARE; SYNDROME;

EID: 84942917215     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0000000000000150     Document Type: Editorial

References (16)

1. Heidenreich PA, Hernandez AF, Yancy CW, et al. Get With The Guidelines program participation, process of care, and outcome for Medicare patients hospitalized with heart failure. Circ Cardiovasc Qual Outcomes 2012; 5:37-43.
2. Pratter MR, Abouzgheib W, Akers S, et al. An algorithmic approach to chronic dyspnea. Respir Med 2011; 105:1014-1021.
3. Nielsen LS, Svanegaard J, Wiggers P, Egeblad H. The yield of a diagnostic hospital dyspnoea clinic for the primary healthcare section. J Intern Med 2001; 250:422-428.
4. Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003; 327:523-528.
5. Currow DC, Higginson IJ, Johnson MJ. Breathlessness-current and emerging mechanisms, measurement and management: a discussion from an European Association of Palliative Care workshop. Palliat Med 2013; 27:932-938.
6. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit care Med 2012; 185: 435-452.
7. Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 2009; 167:53-60.
8. Banzett RB, O'Donnell C, Guilfoyle T, et al. The Multidimensional Dyspnea Profile (MDP): an instrument for clinical and laboratory research. Eur Respir J 2015; 45:1681-1691.
9. Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010; 65:21-26.
10. Higginson IJ, Bausewein C, Reilly CC, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breath-lessness: a randomised controlled trial. Lancet Respir Med 2014; 2:979-987.
11. Fletcher CM. The clinical diagnosis of pulmonary emphysema; an experimental study. Proc R Soc Med 1952; 45:577-584.
12. Simon ST, Weingartner V, Higginson IJ, et al. Definition, categorization, and terminology of episodic breathlessness: consensus by an international Delphi survey. J Pain Symptom Manage 2014; 47:828-838.
13. Herigstad M, Hayen A, Wiech K, Pattinson KT. Dyspnoea and the brain. Respir Med 2011; 105:809-817.
14. Johnson MJ, Simpson M, Currow DC, et al. Magnetoencephalography to investigate central perception of exercise-induced breathlessness in people with chronic lung disease: a feasibility pilot. BMJ Open 2015; in press.
15. Herigstad M, Hayen A, Evans E, et al. Dyspnea-related cues engage the prefrontal cortex-evidence from functional brain imaging in COPD. Chest. 2015. In press
16. Currow DC, Johnson MJ. Distilling the essence of breathlessness-the first vital symptom. Eur Respir J 2015; 45:1526-1528.